• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Intelligent Health Monitoring Platform Myia Raises $6.75M to Improve Patients Lives Using Apple Watch, Fitbit, Motiv Ring

by Jasmine Pennic 12/04/2018 Leave a Comment

 Intelligent Health Monitoring Platform Myia Raises $6.75M to Improve Patients Lives Using Apple Watch, Fitbit, Motiv Ring

Intelligent health monitoring platform Myia Labs Inc. today announced it has raised $6.75M in seed funding led by applied artificial intelligence investors BootstrapLabs and Zetta Venture Partners with participation from the American College of Cardiology and The Boston Consulting Group. Myia harnesses the power of market wearables such as Apple Watch, Fitbit and Motiv’s Ring to monitor chronically ill patients and predict relapses before they happen. 

According to the American College of Cardiology, an advanced cardiovascular disease like heart failure affects over 6.5 million Americans and is one of the largest drivers of hospital admissions in the U.S., many of which are preventable by proactive lifestyle and medication adjustments. Notably, evidence suggests that approximately 1% of heart failure patients today are at target medication doses.

Myia specializes the sensor mix for the condition. For some conditions this could mean a bed sensor, others a blood pressure cuff or a scale. Through machine learning, it relays changes in conditions to doctors. The tech monitors metrics like heart rate, heart rate variability, respiratory rate, blood pressure, sleep data, and gait/balance. In addition, the platform enables patients with chronic and post-operative conditions, like heart failure, to avoid emergency hospital visits and sets a new bar on the quality of life for those who are aging or homebound. 

“We’ve had streams of real-world health data for years, but only now with the advances of machine learning and AI techniques can we start turning this data into trustworthy, actionable clinical insights, and scale preventative virtual care in an unprecedented way,” said Myia CEO Simon MacGibbon. “Many of these biometric markers of patient health status have been established in academic settings but have not been accessible and translated for practical use. We’re excited to be partnering with leaders in the medical profession to bring real-world insight into the clinic. 

 

“At the same time, patients, regardless of their means or confidence in technology, become more empowered and less anxious knowing that their care team is kept up-to-date.”

Tagged With: Applied AI, Artificial Intelligence, Artificial Intelligence (AI) Software Platform, Myia Labs, Smart health monitoring

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |